EFG International AG bought a new stake in Envista Holdings Corporation (NYSE:NVST – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 181,986 shares of the company’s stock, valued at approximately $4,797,000. EFG International AG owned about 0.11% of Envista at the end of the most recent quarter.
A number of other institutional investors have also modified their holdings of the stock. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Envista during the second quarter worth approximately $25,000. Caitong International Asset Management Co. Ltd increased its stake in Envista by 16,711.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after buying an additional 1,504 shares during the period. Allworth Financial LP increased its stake in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the period. UMB Bank n.a. raised its position in Envista by 46.1% during the 4th quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Envista by 73.1% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares during the last quarter.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the stock. Mizuho set a $29.00 target price on shares of Envista in a report on Thursday, August 6th. Robert W. Baird set a $34.00 price target on shares of Envista in a report on Thursday, August 6th. Zacks Research upgraded shares of Envista from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 7th. Evercore reaffirmed an “outperform” rating and issued a $33.00 price objective on shares of Envista in a report on Thursday, May 7th. Finally, BMO Capital Markets began coverage on Envista in a research report on Wednesday, July 8th. They set a “market perform” rating and a $27.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Envista has an average rating of “Moderate Buy” and an average price target of $29.31.
Envista Price Performance
Shares of NYSE NVST opened at $27.52 on Wednesday. The firm has a market capitalization of $4.42 billion, a P/E ratio of 47.44, a PEG ratio of 1.30 and a beta of 0.86. Envista Holdings Corporation has a one year low of $18.77 and a one year high of $30.42. The company’s fifty day moving average is $27.00 and its two-hundred day moving average is $26.36. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.07 and a current ratio of 2.43.
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The business had revenue of $730.50 million for the quarter, compared to analysts’ expectations of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.26 EPS. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. Analysts forecast that Envista Holdings Corporation will post 1.53 EPS for the current fiscal year.
Insider Buying and Selling
In other Envista news, SVP Mischa Reis sold 8,000 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $27.50, for a total transaction of $220,000.00. Following the transaction, the senior vice president directly owned 27,321 shares in the company, valued at approximately $751,327.50. This represents a 22.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.99% of the company’s stock.
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Read More
- Five stocks we like better than Envista
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
